Risk factors for maternal cardiac and obstetric outcomes in patients with and without CHD

Ciara Brown1, Sarah Voskamp2, Alicia Kube3

  • 1George Washington University School of Medicine and Health Sciences, Washington, DC, USA.

Cardiology in the Young
|August 22, 2025
PubMed

Insights

Women with congenital heart disease (CHD) face higher risks of cardiac and obstetric complications during pregnancy. Their hospital stays are also longer, influenced by the severity of their heart condition.

Area of Science:

  • Cardiology
  • Obstetrics
  • Maternal-Fetal Medicine

Background:

  • Peripartum physiological changes increase morbidity risk for women with congenital heart disease (CHD).
  • This study compares peripartum complications and length of stay in women with and without CHD.

Purpose of the Study:

  • To examine factors associated with peripartum complications in women with CHD.
  • To compare length of stay for women with and without CHD during the peripartum period.

Main Methods:

  • Retrospective case-control study of women with CHD and a control group (2000-2017).
  • Analysis of clinical and echocardiographic data to assess baseline characteristics, disease severity, and adverse outcomes.
  • Multivariable regression to evaluate the relationship between maternal CHD, characteristics, and peripartum events.

Main Results:

  • Women with CHD had higher rates of cardiac complications (e.g., arrhythmia) and obstetric events (e.g., caesarean delivery).
  • Increasing maternal age correlated with increased composite cardiac events.
  • Hospital length of stay was significantly longer for women with CHD and associated with disease severity.

Conclusions:

  • Women with CHD experience greater cardiac and obstetric morbidity during peripartum admissions.
  • Increased length of hospital stay in women with CHD is linked to their underlying heart disease severity.
Abstract

Related Concept Videos

Pathophysiology of Cardiac Performance01:29

Pathophysiology of Cardiac Performance

Typical heart performance is influenced by heart rate, rhythm, myocardial contraction, and metabolism or blood flow. The cardiac muscle exhibits distinct electrophysiological features, including pacemaker activity and calcium channel control, which play a vital role in the heart's response to various drugs. The autonomic nervous system, comprising the sympathetic and parasympathetic branches, regulates heart rate. Sympathetic activation increases heart rate, while parasympathetic activation...
800
Mitral Valve Prolapse III: Nursing Management01:19

Mitral Valve Prolapse III: Nursing Management

The nursing management of Mitral Valve Prolapse, or MVP, centers around patient education, symptom monitoring, and lifestyle modifications.Patient Education on MVP Diagnosis and Heredity: Nurses should provide comprehensive education about MVP, a condition where the mitral valve does not close appropriately during heartbeats. This education often includes the condition's pathophysiology, symptoms, and potential complications, like arrhythmias or mitral regurgitation. Though not fully...
36
Imbalances in Cardiac Output01:26

Imbalances in Cardiac Output

The heart's primary function is to pump blood throughout the body, maintaining a balance between blood sent out (cardiac output) and blood returning (venous return). If this balance is disrupted, it can result in congestive heart failure (CHF), a severe condition where the heart becomes an inefficient pump, leading to inadequate blood circulation.
CHF can occur due to the failure of either side of the heart. Left-side failure leads to pulmonary congestion—the right side continues to send...
1.5K
Heart Failure I: Introduction01:27

Heart Failure I: Introduction

Heart failure refers to a clinical syndrome caused by structural or functional cardiac disorders that prevent the heart from pumping an adequate amount of blood to meet the body's metabolic needs. This condition often arises from myocardial infarction or ischemia, leading to decreased cardiac output, reduced tissue perfusion, impaired gas exchange, fluid volume imbalance, and decreased functional ability.Heart failure can result from disruptions in the mechanisms that regulate cardiac output...
54
Mitral Stenosis I: Introduction01:22

Mitral Stenosis I: Introduction

Mitral Valve Stenosis (MVS) is a heart condition where the mitral valve narrows, impeding blood circulation from the left atrium to the left ventricle. The etiology and pathophysiology of this condition are multifaceted, leading to a cascade of cardiovascular complications.Causes of Mitral Valve StenosisRheumatic Heart Disease: It is the main cause of mitral valve stenosis, particularly in developing nations. This condition arises from rheumatic fever, an inflammatory illness resulting from...
34
Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
47